Volkov, A V <br/><br/>
[Bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases].  [electronic resource] 

 -  Terapevticheskii arkhiv  2014 
 - 32-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0040-3660 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antihypertensive Agents--administration & dosage<br/>Bosentan<br/>Chemical and Drug Induced Liver Injury--diagnosis<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Drug Monitoring<br/>Drug Therapy, Combination<br/>Endothelin Receptor Antagonists<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--diagnosis<br/>Kaplan-Meier Estimate<br/>Lupus Erythematosus, Systemic--complications<br/>Male<br/>Middle Aged<br/>Scleroderma, Systemic--complications<br/>Sulfonamides--administration & dosage<br/>Survival Rate<br/>Treatment Outcome